Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M200016-MCP200 on May 14, 2002.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200016-MCP200v1
1/5/366    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zabel, C.
Right arrow Articles by Klose, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zabel, C.
Right arrow Articles by Klose, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 1:366-375, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Alterations in the Mouse and Human Proteome Caused by Huntington’s Disease*

Claus Zabel{ddagger}, Daniel C. Chamrad§, Josef Priller, Ben Woodman||, Helmut E. Meyer§,**, Gillian P. Bates|| and Joachim Klose{ddagger},{ddagger}{ddagger}

{ddagger} Institut für Humangenetik, Universitätsklinikum Charité, 13353 Berlin, Germany
§ Protagen AG, 44227 Dortmund, Germany
Klinik für Neurologie, Universitätsklinikum Charité, 10117 Berlin, Germany
|| Division of Medical and Molecular Genetics, GKT School of Medicine, Guy’s Hospital, London SE1 9RT, United Kingdom
** Institut für Physiologische Chemie, Ruhr-Universität Bochum, 44780 Bochum, Germany

Huntington’s disease is an autosomal dominantly inherited disease that usually starts in midlife and inevitably leads to death. In our effort to identify proteins involved in processes upstream or downstream of the disease-causing huntingtin, we studied the proteome of a well established mouse model by large gel two-dimensional electrophoresis. We could demonstrate for the first time at the protein level that {alpha}1-antitrypsin and {alpha}B-crystalline both decrease in expression over the course of disease. Importantly, the {alpha}1-antitrypsin decrease in the brain precedes that in liver and testes in mice. Reduced expression of the serine protease inhibitors {alpha}1-antitrypsin and contraspin was found in liver, heart, and testes close to terminal disease. Decreased expression of the chaperone {alpha}B-crystallin was found exclusively in the brain. In three brain regions obtained post-mortem from Huntington’s disease patients, {alpha}1-antitrypsin expression was also altered. Reduced expression of the major urinary proteins not found in the brain was seen in the liver of affected mice, demonstrating that the disease exerts its influence outside the brain of transgenic mice at the protein level. Maintaining {alpha}1-antitrypsin and {alpha}B-crystallin availability during the course of Huntington’s disease might prevent neuronal cell death and therefore could be useful in delaying the disease progression.

{ddagger}{ddagger} To whom correspondence should be addressed: Charité, Humboldt Universität, Inst. für Humangenetik, Augustenburger Platz 1, 13353 Berlin, Germany. Tel.: 49-30-450-566133; Fax: 49-30-450-566904; E-mail: joachim.klose{at}charite.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
C. Zabel, L. Mao, B. Woodman, M. Rohe, M. A. Wacker, Y. Klare, A. Koppelstatter, G. Nebrich, O. Klein, S. Grams, et al.
A Large Number of Protein Expression Changes Occur Early in Life and Precede Phenotype Onset in a Mouse Model for Huntington Disease
Mol. Cell. Proteomics, April 1, 2009; 8(4): 720 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Q. Fang, A. Strand, W. Law, V. M. Faca, M. P. Fitzgibbon, N. Hamel, B. Houle, X. Liu, D. H. May, G. Poschmann, et al.
Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease
Mol. Cell. Proteomics, March 1, 2009; 8(3): 451 - 466.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. J. Macario and E. C. de Macario
Sick Chaperones, Cellular Stress, and Disease
N. Engl. J. Med., October 6, 2005; 353(14): 1489 - 1501.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. G. Hay, K. Sathasivam, S. Tobaben, B. Stahl, M. Marber, R. Mestril, A. Mahal, D. L. Smith, B. Woodman, and G. P. Bates
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach
Hum. Mol. Genet., July 1, 2004; 13(13): 1389 - 1405.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
K. C. Hansen, G. Schmitt-Ulms, R. J. Chalkley, J. Hirsch, M. A. Baldwin, and A. L. Burlingame
Mass Spectrometric Analysis of Protein Mixtures at Low Levels Using Cleavable 13C-Isotope-coded Affinity Tag and Multidimensional Chromatography
Mol. Cell. Proteomics, May 1, 2003; 2(5): 299 - 314.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement